FIELD: medicine.
SUBSTANCE: invention is a method for prediction of arterial hypertension (AH) development among the Shors having renal dysfunction (RD). The method considers age, body weight, waist circumference (WC), waist circumference and hip circumference (IWH) ration, presence of hyperuricemia, salt abuse, total cholesterol (TC) level, triglyceride (TG) level, low density lipoprotein cholesterol (LDLC) level. In addition, the following markers are determined: growth, albuminuria (AU), high-density cholesterol (HDC) level, genetic markers: genes of endothelial nitric oxide synthase (eNOS) systems, angiotensin converting enzyme (ACE), methylenetetrahydrofolate reductase (MTHFR). A prognostic coefficient (PC) is scored for each factor. The derived PCs are summed up. With a PC score of +6 points and above, predisposition is predicted for hypertension development of in the Shors, the indigenous inhabitants of Mountaineous Shoria having renal dysfunction.
EFFECT: implementation of the invention allows to predict the risk of arterial hypertension development in the Shors.
2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF RISK OF DEVELOPMENT OF ARTERIAL HYPERTENSION IN TUBALARS, ETHNIC GROUP NATIVE TO ALTAI REPUBLIC | 2012 |
|
RU2505814C1 |
| METHOD FOR DETECTING PREDISPOSITION TO COMORBIDITY OF PANCREATIC DYSFUNCTION IN ADULTS WITH ARTERIAL HYPERTENSION IN CONDITIONS OF BLOOD CONTAMINATION WITH BENZENE | 2020 |
|
RU2751594C1 |
| METHOD FOR PREDICTION OF EARLY POST-INFARCTION ANGINA IN PATIENTS WITH ACUTE ST-ELEVATION MYOCARDIAL INFARCTION ACROSS STAYING IN HOSPITAL | 2014 |
|
RU2543356C1 |
| METHOD OF PREDICTING THE PROBABILITY OF DEVELOPING ARTERIAL HYPERTENSION IN MINERS WITH ANTHRACOSILICOSIS | 2022 |
|
RU2798725C1 |
| METHOD OF PREDICTION OF ASPIRIN RESISTANCE | 2015 |
|
RU2602664C1 |
| METHOD FOR PREDICTING CARDIOVASCULAR RISK BY DETERMINING THE LEVEL OF ESTROGENS | 2021 |
|
RU2770550C1 |
| METHOD OF PREDICTING THE RISK OF DEVELOPING TYPE 2 DIABETES MELLITUS IN OBESE AND/OR PRE-DIABETIC INDIVIDUALS | 2022 |
|
RU2801174C1 |
| METHOD FOR PREDICTING AN INDIVIDUAL RISK OF INCREASED BASAL GLYCEMIA AFTER SIX MONTHS FROM THE START OF STATIN THERAPY | 2017 |
|
RU2642986C1 |
| METHOD OF DETERMINING EFFECTIVENESS OF TREATMENT OF ENDOTHELIAL DYSFUNCTION IN METABOLIC AND FUNCTIONAL DISORDERS IN EXPERIMENTAL RATS | 2023 |
|
RU2808420C1 |
| METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH METABOLIC SYNDROME WITH VITAMIN D DEFICIENCY | 2018 |
|
RU2694842C1 |
